GLOBALKRATOM.ORG · Evidence-based policy resources
Federal Court Record · Four-Part Series

The Utah Files

A document-based examination of what the federal court record in Botanic Tonics, LLC and Global Kratom Coalition, Inc. v. Utah officials reveals about mitragynine pseudoindoxyl, kratom safety claims, clinical evidence, botanical identity and commercial processing.

Case No. 2:26-cv-00267-HCN-DBP · U.S. District Court for the District of Utah
4Investigative parts
FederalDistrict court record
PrimarySource documents
Full PDFAvailable to readers

What Are The Utah Files?

In 2026, Botanic Tonics and the Global Kratom Coalition challenged Utah officials in federal court over the state's Kratom Regulation Act. The resulting record contains far more than legal argument. It includes sworn declarations, laboratory reports, expert analyses, scientific literature, product-quality records and competing claims about what kratom research actually establishes.

The Utah Files is a four-part review of that record. Each installment separates allegations from evidence, attributes expert opinions to the people who made them, and points readers back to the underlying federal court documents.

Important: A statement in a complaint is an allegation, not a judicial finding. A sworn declaration is testimony from the declarant. Expert reports are opinions. Laboratory exhibits are described according to what the submitted records report. The series will distinguish among them.

For Lawmakers: 60-Second Brief

Short on time? Start with the legislative brief: four regulatory questions raised by the federal court record, plus a checklist of questions to ask before voting on kratom legislation.

Open the Legislative Brief
Part I

The MP Problem

The kratom industry tells a federal court that mitragynine pseudoindoxyl is endogenous to natural kratom.

  • Botanic Tonics' MP position in federal court
  • Commercial leaf testing and reported MP detections
  • Utah's Schedule I provision
  • What presence does — and does not — establish
  • The changing scientific and industry narrative around MP
Series articleRead Part I →
Part II

What Their Own Experts Admit

Addiction, withdrawal, liver injury, drug interactions and the limits of the kratom safety evidence.

  • Statements inside plaintiffs' own expert materials
  • Dependence, withdrawal and addiction
  • Neurological and hepatic concerns
  • Mitragynine metabolism to 7-hydroxymitragynine
  • Where the experts agree — and where they disagree
Series articleRead Part II →
Part III

The “14 Clinical Trials” Claim

Botanic Tonics says the clinical evidence establishes safety. Utah's State Chemist disputes that characterization.

  • The 14-study claim in the pleadings
  • The short-duration Feel Free study
  • The FDA-funded human study
  • What the studies were designed to answer
  • Whether the conclusions reach farther than the evidence
Series articleRead Part III →
Part IV

What's Actually in the Bag?

Botanical identity, out-of-specification findings, microbial controls and what “natural leaf” processing looks like in the court record.

  • Botanical identity testing and OOS findings
  • Recommended confirmatory testing
  • Bacteria and microbial-control processing
  • Heated chlorinated water and commercial leaf treatment
  • The unanswered quality-control questions
Series articleRead Part IV →

Read the Full Court Record

Global Kratom Policy Review is making the combined federal court documents used for this series available so readers, researchers, journalists and lawmakers can examine the underlying record themselves.

Open the Full Court Documents (PDF)
Primary source archive · Botanic Tonics, LLC and Global Kratom Coalition, Inc. v. Pehrson et al. · Case No. 2:26-cv-00267-HCN-DBP

How This Series Will Be Reported

The purpose is not to treat every sentence filed in litigation as established fact. It is to show what entered the federal record, identify who made each claim, compare competing representations of the science, and make the source documents available for independent review.

Where an installment uses material outside PACER for scientific or historical context, that material will be identified separately from the court record.